Related Experiment Video
Updated: Aug 11, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Serotypes of hepatitis C virus in mixed cryoglobulinaemia]
P Marson1, M Vicarioto, C Donadel
1Servizio di Immunoematologia e Trasfusionale, Azienda Ospedaliera, Padova.
Insights
Hepatitis C virus (HCV) serotyping in mixed cryoglobulinaemia (MC) patients revealed a predominance of serotype 1 (46.4%). This study provides the first serotypic characterization of HCV in MC patients, reflecting North Italian genotypic distribution.
Area of Science:
- Virology
- Immunology
- Hepatology
Context:
- Mixed cryoglobulinaemia (MC) is a common extra-hepatic manifestation of Hepatitis C virus (HCV) infection.
- Previous research focused on HCV genotypic distribution in MC, but serotypic data were lacking.
Purpose:
- To determine the HCV serotypic distribution in patients with mixed cryoglobulinaemia.
- To compare serotypic findings with existing genotypic data in the Venetian area.
Summary:
- A serotyping enzyme immunoassay was performed on 28 HCV-positive MC patients.
- HCV serotype 1 was detected in 46.4% of patients, followed by serotype 2 (17.9%).
- Mixed serotypes were observed in 10.7% of cases, and serotype was undetectable in 25.0%.
Impact:
- This study provides the first serological characterization of HCV in MC patients.
- Findings align with genotypic distribution data from North Italy, suggesting regional patterns.
- The results can inform understanding of HCV pathogenesis in MC and guide regional epidemiological studies.
Background:
Several authors have studied the genotypic distribution of hepatitis C virus (HCV) in mixed cryoglobulinaemia (MC), which represents the most typical extra-hepatic manifestation of the HCV infection. On the other hand, at present no data are available on the HCV serotypic characterization of MC patients.
Methods:
Thus, 28 serum specimens from HCV positive patients affected by MC (7 males and 21 females; mean age of 64 yrs, range 35-80) have been evaluated by a serotyping EIA method (Murex HCV Serotyping 1-6 Assay, Murex Diagnostics, Pomezia, Italy).
Results:
The HCV serotype 1 was found in 13 patients (46.4%), serotype 2 in 5 patients (17.9%) and mixed serotypes in 3 patients (10.7%), showing, respectively, serotypes 1+2, 1+4, and 1+4+5. Moreover, the HCV serotype was not detectable in 7 patients (25.0%).
Conclusions:
These results, obtained by using a simple, serologic technique, agree with some literature data concerning MC patients from the same geographic region as ours (Venetian area). In addition, our findings appears to reflect merely the genotypic distribution of the HCV infection in the North Italy.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease

